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doi:10.1016/j.jmii.2011.09.007Splenic abscess is uncommon and is still associated with significant morbidity and mortality.
Gram-negative bacilli are the most commonly isolated organisms, followed by Gram-positive
cocci. However, the predominant organisms found depend on the geographic location. Shewa-
nella putrefaciens is a Gram-negative non-fermentative oxidative bacillus found in the envi-
ronment. Infection usually manifests with a number of clinical syndromes, most commonly
as skin or soft tissue infections, typically in patients whose immune system is compromised.
Intra-abdominal abscess is extremely rare. We report a case of a 22-year-old female who pre-
sented with S. putrefaciens splenic abscesses as the first manifestation of diabetes mellitus,
which was successfully managed with a course of antibiotic therapy.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Splenic abscess is uncommon and is predominantly caused
by Gram-negative bacilli, followed by Gram-positive cocci.
However, the predominant organism varies with geographic
location.1e5 Splenic abscess is usually associated with
dissemination from other infected foci. Shewanella ist of Medicine, Raja Isteri
al, Bandar Seri Begawan BA
co.uk (V.H. Chong).
an Society of Microbiology. Publa genus of Gram-negative non-fermentative oxidative
bacilli that usually occur as opportunistic infections in
patients with compromised immunity and are manifest as
a number of clinical syndromes.6,7 We report a case of a 22-
year-old female who presented with Shewanella putref-
aciens splenic abscesses as the first manifestation of
diabetes mellitus.
Case report
A 22-year-old female presented to the outpatient clinic
with a 3-week history of fever and a 2-week history of non-
productive cough. She had been well and did not have anyished by Elsevier Taiwan LLC. All rights reserved.
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acquired pneumonia with a course of oral cefuroxime
(500 mg every 12 hours). Her symptoms failed to resolve, so
she presented at the outpatient clinic again. Physical
examination was unremarkable apart from fever (40C) and
obesity (BMI> 35 kg/m2). Laboratory investigations showed
microcytic anemia, with hemoglobin of 10.5 g/dL (refer-
ence range 12.0e16.0 g/dL), a mean corpuscular volume of
76.2 fL (80e96 fL), leukocytosis (13 109 /mm3, 4.0e11.0),
hyperglycemia (16 mmol/dL, 4.0e11.0), an erythrocyte
sedimentation rate of 127 mm/hour (3e15 mm/hour) and
serum C-reactive protein of 34.2 mg/dL (0.0e0.75 mg/dL).
Chest radiography showed left lower consolidation. An
ultrasound scan of the abdomen showed multiple hypo-
echoic lesions of various sizes (5e10 mm) within the spleen,
a fatty liver, and a small left-sided effusion. Empiric
intravenous cefuroxime (1.5 g every 8 hours) and oral azi-
thromicin (500 mg daily) were started.
The patient’s condition deteriorated and she was
transferred to our tertiary hospital. She later developed
respiratory distress that required intubation and mechan-
ical ventilation and was transferred to the intensive care
unit (ICU). She was then started empirically on intravenous
meropenem (1 g every 8 hours). Her condition rapidly pro-
gressed to septic shock and acute renal failure requiring
ionotropic and dialysis support. Echocardiography was
negative for any valve abnormalities. The first blood culture
(BACTEC) was negative, whereas a second culture carried
out 2 days later (both taken in the previous hospital) con-
tained a Gram-negative bacillus that was resistant to ami-
noglycoside, ampicillin and first-generation cephalosporins,
but was sensitive to amoxicillin-clavulanic acid, ceftazi-
dime, imipenem, ciprofloxacin and tetracycline (Kirby
Bauer agar diffusion method and interpretation following
CLSI, version 1.0.0209). The organism was later identified
as S. putrefaciens (API 20NE, Biomerieux, Marcy L’Etoile,
France). The sensitivity pattern resembled that of Bur-
kholderia pseudomallei, an organism that we regularly
encounter, so we initially considered the possibility of
misidentification. Subsequently, two other blood cultures
obtained after the patient was transferred to our institu-
tion revealed the same organism using the same identifi-
cation methods and antibiotic sensitivity testing with
a sensitivity of 99.6% on the API system.
A computed tomography (CT) scan confirmed multiple
splenic lesions consistent with abscesses (Fig. 1A), left lower
lobe consolidation, and bilateral pleural effusions. A sputum
culture was positive for Streptococcus pneumoniae and urineFigure 1. Axial computed tomography images showing (A) mu
(B) regression of the splenic abscesses 2 months later, and (C) complwas positive for Candida albicans. Antibiotic therapy was
later stepped down to intravenous ceftazidime (1 g every 8
hours) and amoxicillin-clavulanic acid (1.2 g every 8 hours).
The patient developed an adverse effect (cephalosporin-
related hemolysis) before we could increase the ceftazidime
to 2 g. Ceftazidime was changed to intravenous ciprofloxacin
(400 mg every 12 hours). Percutaneous aspiration of the
splenic abscesses was considered, but was not necessary
because the patient’s condition started to improve.
After 18 days in the ICU, the patient was transferred to
a general ward. She was doing well until Day 28, when she
developed acute respiratory distress requiring intubation
and ventilation. Acute pulmonary embolism was suspected.
A high-resolution CT scan showed only left lower lobe
collapse and no evidence of pulmonary embolism. Regular
chest physiotherapy led to tracheal aspiration of thick
mucus and this resulted in an improvement in her condition.
In addition, she developed critical illness neuropathies,
confirmed by nerve conduction studies. She also had left
vocal-cord palsy, which was also attributed to the neurop-
athy. After a further 7-day ICU stay, she was transferred to
a general ward. A follow-up CT scan on Day 39 revealed
regression of the splenic abscesses (Fig. 1B). Her antibiotic
therapy was changed to oral ciprofloxacin (500 mg every 8
hours) and she was discharged on Day 61. A follow-up CT
scan 6 weeks later revealed only slight regression of the
abscesses and the antibiotic was continued. A repeat CT
scan 3 months later revealed complete resolution of the
splenic abscesses and the antibiotic was discontinued
(Fig. 1C). She remained well and her diabetes was under
control with oral hypoglycemic agents.Discussion
Despite improvements in healthcare provision, splenic
abscess is still universally fatal if untreated. Even with
treatment, mortality remains significant (12e47%).1,3,8 In
a large series from Taiwan, the presence of multiple
abscesses, Gram-negative bacilli etiology and high APACHE
II score were significantly associated with higher mortality.3
Splenectomy was once considered the gold standard
treatment, but is now reserved for patients with large
abscess> 10 cm or those who fail to respond to nonsurgical
treatments.9,10,11 Imaging-guided percutaneous aspiration
has also been shown to be safe and effective.
The organismsmost commonly isolated include Klebsiella
pneumoniae, Escherichia coli, Streptococcus species andltiple hypoechoic lesions consistent with splenic abscesses,
ete regression of the splenic abscesses 6 months after diagnosis.
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have also been reported to cause splenic abscess. It has
been reported that polymicrobial-associated splenic abscess
accounts for 36% of cases. In Taiwan, K. pneumoniae is
the most common cause, whereas B. pseudomallei is
the predominant organism isolated in Thailand and
Singapore.1e4 B. pseudomallei is also the most commonly
implicated organism in our local setting. According to
a previous report from Singapore, S. aureus was the
predominant organism.5 Mycobacterium tuberculosis,
although becoming less common, is still an important cause
and should not be forgotten in view of the resurgence of this
infection.12 Thus, the microbial spectrum of splenic abscess
seems to be changing.
S. putrefaciens, previously known as Pseudomonas
putrefaciens, is commonly found in water-related envi-
ronments (freshwater, seawater, lakes, rivers and
sewage).7,13 Therefore, exposure to contaminated water
has usually occurred and patients typically have skin breaks
such as ulcers or open wounds as a port of entry.
S. putrefaciens is associated with skin and soft-tissue
infections (fulminant periorbital cellulitis, dacrycystitis,
finger and perianal abscesses), hepatobiliary infections,
empyema, and pneumonia in premature babies.6,7 In most
instances, S. putrefaciens is isolated with other organisms.
Predisposing factors include underlying malignancy, hep-
atobiliary disease, diabetes mellitus, renal failure, neu-
tropenia and prematurity where the immune system is
compromised.6,7,14,15 In our case, it is likely that diabetes
mellitus had been present for some time, but was only
diagnosed on the latest presentation.
To date, there is only one report of splenic abscess in
association with S. putrefaciens in the English literature.15
The patient was a 69-year-old male with a history of
coronary artery bypass, diabetes mellitus, previous chole-
cystectomy and renal failure on continuous ambulatory
peritoneal dialysis. He had a leg ulcer and had been
exposed to river water. The ulcer was the likely port of
entry. A blood culture contained S. putrefaciens, whereas
ascitic fluid contained a mixture of organisms that included
K. pneumoniae, Proteus mirabilis, and S. putrefaciens. He
failed to respond to catheter drainage and prolonged
antibiotics, so splenectomy was necessary. Our patient
represents the second case of S. putrefaciens splenic
abscess reported in the literature.
Apart from the rarity of Shewanella splenic abscess,
there was another interesting aspect to our case. The
sensitivity pattern for the isolated organism was different to
what has been reported. S. putrefaciens is typically sensi-
tive to aminoglycosides, whereas in our case the organism
was resistant.14 We initially considered the possibility of
misidentification of B. pseudomallei, as previously reported
in the literature.16 However, subsequent blood cultures
from our center using the same isolation, identification and
antibiotic sensitivity testing methods following strict
criteria led to isolation of the same organism with a similar
sensitivity pattern. Our microbiology laboratory follows
well-established screening tests (Gram stain, oxidase test,
bipolar staining and colony morphology) and uses the API
20NE system. Unfortunately, no molecular testing facility is
available and the laboratory used only the Kirby-Bauer
diffusion method with interpretation following the CSLIprotocol for identification. Finally, our patient responded to
a course of a single antimicrobial. Use of single agent with
the exception of cotrimoxazole has always resulted in
relapse of melioidosis. The present case remained well after
stopping antibiotic treatment.
In conclusion, our case highlights a rare cause of splenic
abscess. Our patient presented with a Shewanella splenic
abscess as the first manifestation of underlying diabetes
mellitus. The infection was successfully managed with
a prolonged course of antibiotic therapy without the need
for drainage or surgery.
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